In conclusion, our study revealed that MALAT1 rs3200401 CT + TT genotypes could be a risk factor for MACCEs in MI patients, suggesting that the MALAT1 gene may become a biomarker for poor prognosis in MI patients. This evidence concerns the gene MALAT1 and myocardial infarction.